To include your compound in the COVID-19 Resource Center, submit it here.

Altor BioScience, NantKwest deal

Altor and NantKwest partnered to co-develop cancer therapies using Altor’s ALT-803 and ALT-801

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE